VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AMRXAmneal Pharmaceuticals, Inc.
$16.92$5.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMRXPrice History

AMRX logoAmneal Pharmaceuticals, Inc. (AMRX) Stock Price History

Historical prices from 2009 to 2026

$16.92-0.23  (-1.34%)close Jul 6
Returns
1M
+23.4%
3M
+37.0%
YTD
+33.6%
1Y
+101.2%
3Y
+78.8%
5Y
+26.9%
ATH$52.10Apr 2015-67.5%
ATL$1.24Mar 2023pre-split
Avg Vol (50D)1.6M/ day
52-Week Range$7.67 — $17.86
LowCurrent: $16.92High

Loading 10-year price history...

AMRX Historical Performance

1 YearTotal Return
+101.2%
Price: +101.2%
3 YearsTotal Return
+471.6%
CAGR: +78.8%
Price: +471.6%
5 YearsTotal Return
+228.5%
CAGR: +26.9%
Price: +228.5%
YTD
+33.6%

AMRX Annual Returns

Year-by-year price performance · 2009–2026

Best+187.7%2023
Worst-68.7%2016
Up years11/18
2009+186.5%
2010+42.7%
2011-4.3%
2012+0.1%
2013+21.7%
2014+27.6%
2015+34.5%
2016-68.7%
2017+22.9%
2018-23.1%
2019-65.8%
2020-4.2%
2021-1.8%
2022-59.0%
2023+187.7%
2024+32.4%
2025+62.4%
2026+9.1%
2009 annual price return
+186.5%
2010 annual price return
+42.7%
2011 annual price return
-4.3%
2012 annual price return
+0.1%
2013 annual price return
+21.7%
2014 annual price return
+27.6%
2015 annual price return
+34.5%
2016 annual price return
-68.7%
2017 annual price return
+22.9%
2018 annual price return
-23.1%
2019 annual price return
-65.8%
2020 annual price return
-4.2%
2021 annual price return
-1.8%
2022 annual price return
-59.0%
2023 annual price return
+187.7%
2024 annual price return
+32.4%
2025 annual price return
+62.4%
2026 annual price return
+9.1%
LessMore
Alpha vs S&P 500
1Y+91.6%
3Y+60.2%
5Y+14.4%

Price returns only.

Download Historical Data

4,393 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

AMRX Stock Price Trajectory (2009–2026)

As of July 7, 2026, Amneal Pharmaceuticals, Inc. (AMRX) trades at $16.92, representing a +101.2% return over the past year. The stock has delivered a +228.5% total return over five years (+26.9% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $52.10 on April 9, 2015. From this peak, AMRX has corrected -67.5%, currently trading 33% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers TEVA (+98.5% 1Y), VTRS (+82.6% 1Y), and PRGO (-58.5% 1Y), AMRX has underperformed the peer group average. Compare AMRX vs TEVA →

AMRX Historical Price Data · from 2009

Rows 1–50 of 4,393
Date Open High Low Close Volume Change %
2026-07-0617.2517.3616.9216.921.63M-1.34%
2026-07-0217.0617.3416.9617.151.39M+1.06%
2026-07-0117.3217.4616.7316.971.57M-1.96%
2026-06-3017.3017.4917.1717.312.11M+0.12%
2026-06-2917.1117.4316.8717.292.40M+0.35%
2026-06-2617.2717.8617.1217.230-0.52%
2026-06-2517.3917.7717.2117.322.12M+0.29%
2026-06-2416.8917.4016.8117.271.67M+3.66%
2026-06-2316.1816.7315.9316.661.53M+3.41%
2026-06-2216.3316.4016.0216.111.71M-0.62%
2026-06-1816.4416.6115.7316.212.64M-0.43%
2026-06-1716.2516.5516.1816.281.57M+0.18%
2026-06-1616.3016.3416.0116.251.67M+0.06%
2026-06-1516.1216.3615.7316.242.27M+0.25%
2026-06-1216.4816.6116.1816.202.24M-0.86%
2026-06-1115.4516.3415.3316.342.96M+6.66%
2026-06-1014.6915.6414.6515.323.28M+4.29%
2026-06-0913.9014.7313.7914.692.27M+7.15%
2026-06-0813.7913.9613.7013.711.16M-0.29%
2026-06-0513.6313.8813.5513.751.25M+1.70%
2026-06-0413.0013.6913.0013.521.64M+5.01%
2026-06-0312.5712.8912.4912.881.16M+1.78%
2026-06-0212.7612.8312.5312.651.19M-1.94%
2026-06-0113.0713.1412.7712.901.28M-2.05%
2026-05-2912.9713.2112.9313.171.54M+1.70%
2026-05-2812.8013.0212.6912.951.99M+1.33%
2026-05-2712.8513.0612.7712.781.37M-0.08%
2026-05-2612.5412.8112.5412.792.09M+2.98%
2026-05-2212.4612.5312.3412.42855K0.00%
2026-05-2112.1412.4511.9512.421.60M+1.55%
2026-05-2011.9712.2811.8312.231.44M+3.56%
2026-05-1911.8812.0411.7811.811.34M-0.92%
2026-05-1812.0012.2311.8711.921.25M-0.08%
2026-05-1512.1612.2011.8811.931.30M-2.45%
2026-05-1412.4712.5012.1912.231.71M-1.29%
2026-05-1312.4812.6412.3412.391.37M-1.67%
2026-05-1212.8112.8212.5412.601.17M-1.41%
2026-05-1113.1713.2612.7412.781.56M-3.18%
2026-05-0813.6213.8113.1313.201.46M-3.79%
2026-05-0713.6913.8413.5113.721.65M+0.73%
2026-05-0613.6013.7013.4513.621.12M+1.57%
2026-05-0513.0813.4613.0813.41554K+2.29%
2026-05-0412.7213.3312.6713.111.33M+2.18%
2026-05-0112.6612.9512.3812.831.29M-0.31%
2026-04-3012.8012.9712.7212.871.82M+0.55%
2026-04-2912.5112.8512.5112.801.71M+0.51%
2026-04-2812.6912.8712.5212.731.06M+1.31%
2026-04-2712.5712.9712.5212.571.32M+0.40%
2026-04-2412.5812.6712.3512.521.68M-1.03%
2026-04-2312.8212.9612.4812.651.52M-1.33%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AMRX — Frequently Asked Questions

Quick answers to the most common questions about buying AMRX stock.

How has AMRX stock performed recently?

AMRX returned +101.2% over the past year, beating its 5-year annualized CAGR of +26.9%. The stock trades above its 200-day moving average, confirming the uptrend.

What is AMRX's all-time high price?

Amneal Pharmaceuticals, Inc. reached $52.10 on 2015-04-09. The 52-week high is $17.86. Current 1-year return of +101.2% places the stock closer to historical peaks.

Where can I download AMRX historical price data?

This page provides AMRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2009-2026, downloadable in CSV format.

489 data points · sampled from 4,393